CC Pharma GmbH of Germany has received a first shipment of EU-compliant GMP hemp seedlings for CBD production from parent company Aphria Inc., Ontario, Canada to a newly opened Aphria indoor R&D and growing facility in Neumünster, Germany, the companies announced. CC Pharma distributes pharmaceutical products to more than 13,000 pharmacies in Germany and is on the list of approved German medical marijuana importers. Aphria, which bought CC Pharma for €18.92 million (~$22 million) in cash last year, is traded on the Toronto Stock Exchange and NASDAQ in the USA.
Like HempToday? How you can support us
Your donations help us to keep HempToday open for all readers, regardless of what they can afford to pay. Through this “information equality” we're able to support hemp entrepreneurs and stakeholders all over the world by keeping a spotlight on hemp and all the promise it offers for economic development and healing our planet.